tiprankstipranks
Advertisement
Advertisement

PRTA Stock Latest News

Analyst Reiterates Buy on Prothena, Maintains $30 Price Target on Differentiated TTR-Depleter Opportunity
RatingsAnalyst Reiterates Buy on Prothena, Maintains $30 Price Target on Differentiated TTR-Depleter Opportunity
5d ago
PRTA
3 Stocks Flashing Positive Insider Buying Signals
PremiumMarket News
3 Stocks Flashing Positive Insider Buying Signals
1M ago
PEB
PRTA
Prothena Shareholders Reaffirm Board, Auditor and Pay Policies
PremiumCompany Announcements
Prothena Shareholders Reaffirm Board, Auditor and Pay Policies
2M ago
8K
PRTA
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
PremiumThe Fly
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
3M ago
DYN
ALEC
Analyst Reiterates Buy on Prothena, Maintaining $30 Price Target on CYTOPE and PRX012-TfR Platform Strength
PremiumRatings
Analyst Reiterates Buy on Prothena, Maintaining $30 Price Target on CYTOPE and PRX012-TfR Platform Strength
3M ago
PRTA
Prothena price target raised to $20 from $19 at Citizens
PremiumThe FlyProthena price target raised to $20 from $19 at Citizens
3M ago
PRTA
Prothena reports Q1 EPS 60c vs ($1.12) last year
Premium
The Fly
Prothena reports Q1 EPS 60c vs ($1.12) last year
3M ago
PRTA
Prothena cuts FY26 net cash used view to $18M-$23M from $50M-$55M
Premium
The Fly
Prothena cuts FY26 net cash used view to $18M-$23M from $50M-$55M
3M ago
PRTA
Prothena Corporation (PRTA) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Prothena Corporation (PRTA) Q1 Earnings Cheat Sheet
3M ago
PRTA
Prothena announces Novo Nordisk obtained FDA fast track for PRX004
PremiumThe Fly
Prothena announces Novo Nordisk obtained FDA fast track for PRX004
3M ago
NVO
PRTA
Prothena names Annie Kingston as Chief Strategy Officer
PremiumThe Fly
Prothena names Annie Kingston as Chief Strategy Officer
4M ago
PRTA
Prothena (PRTA): Partner-Funded, Milestone-Rich Pipeline De-Risks Lead Programs and Supports Buy Rating
PremiumRatings
Prothena (PRTA): Partner-Funded, Milestone-Rich Pipeline De-Risks Lead Programs and Supports Buy Rating
5M ago
PRTA
Prothena achieves $50M clinical milestone payment from Novo Nordisk
PremiumThe FlyProthena achieves $50M clinical milestone payment from Novo Nordisk
5M ago
NVO
PRTA
Prothena Announces $100 Million Share Repurchase Program
Premium
Company Announcements
Prothena Announces $100 Million Share Repurchase Program
5M ago
8K
PRTA
Prothena announces $100M share repurchase plan
Premium
The Fly
Prothena announces $100M share repurchase plan
5M ago
PRTA
Prothena expects to end year with $255M in cash, equivalents
PremiumThe Fly
Prothena expects to end year with $255M in cash, equivalents
5M ago
BMY
NVO
Prothena Earnings Call: Pipeline Progress, Risks Ahead
PremiumCompany Announcements
Prothena Earnings Call: Pipeline Progress, Risks Ahead
5M ago
PRTA
Prothena: Transformative CYTOPE and TfR Platforms Underpin Long‑Term Upside and Support Buy Rating
PremiumRatings
Prothena: Transformative CYTOPE and TfR Platforms Underpin Long‑Term Upside and Support Buy Rating
5M ago
PRTA
Prothena reports Q4 EPS (40c), consensus (46c)
PremiumThe Fly
Prothena reports Q4 EPS (40c), consensus (46c)
5M ago
PRTA
PRTA Earnings this Week: How Will it Perform?
PremiumPre-EarningsPRTA Earnings this Week: How Will it Perform?
6M ago
PRTA
Prothena Board Member Paula Cobb Resigns
Premium
Company Announcements
Prothena Board Member Paula Cobb Resigns
8M ago
8K
PRTA
Prothena price target raised to $19 from $11 at Citizens JMP
Premium
The Fly
Prothena price target raised to $19 from $11 at Citizens JMP
8M ago
PRTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >